Through shRNA knockdown experiments using in vitro N2a neuroblastoma cultures transfected with human APP, it was shown that reduced CD2AP expression results in a decrease in cell membrane APP, which would suggest less APP being processed in the endosomes and thus decreasing Aβ release [90]. The gene discussed is APP; the disease is neuroblastoma.